Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Epidemiological studies have shown that coffee consumption decreases the risk of Parkinson’s disease (PD). Caffeic acid (CA) and chlorogenic acid (CGA) are coffee components that have antioxidative properties. Rotenone, a mitochondrial complex I inhibitor, has been used to develop parkinsonian models, because the toxin induces PD-like pathology. Here, we examined the neuroprotective effects of CA and CGA against the rotenone-induced degeneration of central dopaminergic and peripheral enteric neurons. Male C57BL/6J mice were chronically administered rotenone (2.5 mg/kg/day), subcutaneously for four weeks. The animals were orally administered CA or CGA daily for 1 week before rotenone exposure and during the four weeks of rotenone treatment. Administrations of CA or CGA prevented rotenone-induced neurodegeneration of both nigral dopaminergic and intestinal enteric neurons. CA and CGA upregulated the antioxidative molecules, metallothionein (MT)-1,2, in striatal astrocytes of rotenone-injected mice. Primary cultured mesencephalic or enteric cells were pretreated with CA or CGA for 24 h, and then further co-treated with a low dose of rotenone (1–5 nM) for 48 h. The neuroprotective effects and MT upregulation induced by CA and CGA in vivo were reproduced in cultured cells. Our data indicated that intake of coffee components, CA and CGA, enhanced the antioxidative properties of glial cells and prevents rotenone-induced neurodegeneration in both the brain and myenteric plexus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“administration of CA or CGA at least partially prevented the changes induced by rotenone, which affected both neurons and enteric glial cells in the intestinal myenteric plexus of treated mice.”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [224]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Importantly, all these effects were reproduced in vitro.”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [224]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“to reach the substantia nigra, eventually leading to motor dysfunction [5].”
BackgroundChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683 · cited 2×
“Studies have demonstrated neurotoxic effects of rotenone in vitro and in vivo [11,13,14].”
BackgroundGastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839 · cited 1×
“Recently, a large-scale prospective study demonstrated that lower bowel movement frequencies predicted the future PD crisis [4].”
BackgroundAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778 · cited 2×
“Considering the epidemiological data showing an inverse association of daily coffee consumption with PD risk [18,19], we examined the neuroprotective effects of CA and CGA against rotenone neurotoxicity.”
BackgroundSherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708 · cited 1×
“Studies have demonstrated neurotoxic effects of rotenone in vitro and in vivo [11,13,14].”
BackgroundProspective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · cited 2×
“Considering the epidemiological data showing an inverse association of daily coffee consumption with PD risk [18,19], we examined the neuroprotective effects of CA and CGA against rotenone neurotoxicity.”
BackgroundPathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598 · cited 5×
“In addition, rotenone has been shown to reproduce PD pathology in both the CNS and ENS [15–17].”
BackgroundInfluentialA timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594 · cited 5×
“In addition, rotenone has been shown to reproduce PD pathology in both the CNS and ENS [15–17].”
BackgroundInfluentialAlpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469
Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427
Johnson, M. E., & Bobrovskaya, L. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2014.12.002 · Cited by 332 · cited 1×
“Studies have demonstrated neurotoxic effects of rotenone in vitro and in vivo [11,13,14].”
BackgroundBao, L., Li, J., Zha, D., Zhang, L., Gao, P., Yao, T., & Wu, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.021 · Cited by 308
Dodiya, H. B., Forsyth, C. B., Voigt, R. M., Engen, P. A., Patel, J., Shaikh, M., Green, S. J., Naqib, A., Roy, A., Kordower, J. H., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.012 · Cited by 305 · cited 2×
“To examine the effects of CA and CGA on enteric glial cells in the small intestine of rotenonetreated mice, we performed immunostaining of the glial marker, GFAP [33].”
MethodFree radical scavenging actions of metallothionein isoforms I and II
Kumari, M. V. R., Hiramatsu, M., & Ebadi, M. (1998) · Free Radical Research · doi:10.1080/10715769800300111 · Cited by 243
Pesticide/Environmental Exposures and Parkinson's Disease in East Texas
Dhillon, A. S., Tarbutton, G. L., Levin, J. L., Plotkin, G. M., Lowry, L. K., Nalbone, J. T., & Shepherd, S. (2008) · Journal of Agromedicine · doi:10.1080/10599240801986215 · Cited by 238 · cited 1×
“Epidemiological studies suggest that pesticide exposure, particularly rotenone and paraquat, increases the risk of PD [10].”
BackgroundPathological lesions in colonic biopsies during Parkinson’s disease
Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., Naveilhan, P., Galmiche, J.-P., Bruley des Varannes, S., Derkinderen, P., et al. (2008) · Gut · doi:10.1136/gut.2008.162503 · Cited by 229
Pang, C., Zheng, Z., Shi, L., Sheng, Y., Wei, H., Wang, Z., & Ji, L. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.024 · Cited by 210
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203 · cited 1×
“Therefore, it has been hypothesized that PD pathology spreads from the ENS to the CNS via the vagal nerve [9].”
BackgroundLife style risks of Parkinson?s disease: Association between decreased water intake and constipation
Ueki, A., & Otsuka, M. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1706-3 · Cited by 190
Lee, Y., Shin, D., Kim, J., Hong, S., Choi, D., Kim, Y.-J., Kwak, M., & Jung, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.016 · Cited by 147
Han, D., Chen, W., Gu, X., Shan, R., Zou, J., Liu, G., Shahid, M. S., Gao, J., & Han, B. (2017) · Oncotarget · doi:10.18632/oncotarget.14747 · Cited by 143
Shi, A., Shi, H., Wang, Y., Liu, X., Cheng, Y., Li, H., Zhao, H., Wang, S., & Dong, L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.007 · Cited by 143
Shen, W., Qi, R., Zhang, J., Wang, Z., Wang, H., Hu, C., Zhao, Y., Bie, M., Wang, Y., Fu, Y., et al. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.04.010 · Cited by 141
Metallothioneins are multipurpose neuroprotectants during brain pathology
Penkowa, M. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05207.x · Cited by 131 · cited 1×
“The two major isoforms, MT-1 and -2, are often considered physiologically equivalent, because they are expressed in most organs and show coordinated induction in response to various stimulants such as metals, hormones, cytokines, inflammation, and oxidative stress [43,46,47].”
BackgroundEffect of Chlorogenic Acid Supplementation in MPTP-Intoxicated Mouse
Singh, S. S., Rai, S. N., Birla, H., Zahra, W., Kumar, G., Gedda, M. R., Tiwari, N., Patnaik, R., Singh, R. K., & Singh, S. P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00757 · Cited by 125 · cited 2×
“The dosages of CA (30 mg/kg/day) and CGA (50 mg/kg/day) were determined based on previous reports [22,24,25].”
MethodWei, M., Zheng, Z., Shi, L., Jin, Y., & Ji, L. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx230 · Cited by 100
Mubarak, A., Hodgson, J. M., Considine, M. J., Croft, K. D., & Matthews, V. B. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400920x · Cited by 97 · cited 1×
“It has been reported that one cup of coffee contains 70–350 mg of CA [34] and approximately 250 mg of CGA [35].”
BackgroundAstrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity
Miyazaki, I., Asanuma, M., Kikkawa, Y., Takeshima, M., Murakami, S., Miyoshi, K., Sogawa, N., & Kita, T. (2011) · Glia · doi:10.1002/glia.21112 · Cited by 95 · cited 1×
“We previously reported that MT-1,2 were upregulated specifically in striatal astrocytes by activation of the Nrf2 pathway in response to oxidative stress and they protected nigral dopaminergic neurons [48].”
BackgroundSelf-citationMoon, M. K., Lee, Y. J., Kim, J. S., Kang, D. G., & Lee, H. S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1371 · Cited by 95
Schmidt, W., & Alam, M. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_42 · Cited by 94 · cited 1×
“Rotenone, a mitochondrial complex I inhibitor, is used to develop animal models of PD, because the toxin induces dopaminergic neuronal loss and PD motor symptoms [11,12].”
Gastrointestinal Dysfunction in Parkinson’s Disease
Pfeiffer, R. F. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0539-9 · Cited by 94
Barros Silva, R., Santos, N. A. G., Martins, N. M., Ferreira, D. A. S., Barbosa, F., Oliveira Souza, V. C., Kinoshita, Â., Baffa, O., Del-Bel, E., & Santos, A. C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.041 · Cited by 88 · cited 1×
“In those reports, CA and CGA showed antioxidative properties [23,24], anti-inflammatory activity [21,24–26], and inhibitory effects of mitochondrial damage [20].”
BackgroundTsai, S.-J., Chao, C., & Yin, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.171 · Cited by 88
Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model
Kim, J. H., Wang, Q., Choi, J. M., Lee, S., & Cho, E. J. (2015) · Nutrition Research and Practice · doi:10.4162/nrp.2015.9.5.480 · Cited by 87 · cited 1×
“It has been reported that one cup of coffee contains 70–350 mg of CA [34] and approximately 250 mg of CGA [35].”
BackgroundMetallothionein‐I+II in neuroprotection
Pedersen, M. Ø., Jensen, R., Pedersen, D. S., Skjolding, A. D., Hempel, C., Maretty, L., & Penkowa, M. (2009) · BioFactors · doi:10.1002/biof.44 · Cited by 84 · cited 1×
“The two major isoforms, MT-1 and -2, are often considered physiologically equivalent, because they are expressed in most organs and show coordinated induction in response to various stimulants such as metals, hormones, cytokines, inflammation, and oxidative stress [43,46,47].”
BackgroundKurauchi, Y., Hisatsune, A., Isohama, Y., Mishima, S., & Katsuki, H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01833.x · Cited by 83 · cited 2×
“The dosages of CA (30 mg/kg/day) and CGA (50 mg/kg/day) were determined based on previous reports [22,24,25].”
MethodGomes, P. M., Chevalier, J., Boesmans, W., Roosen, L., den Abbeel, V. V., Neunlist, M., Tack, J. F., & Berghe, P. V. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01302.x · Cited by 83
Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models
Miyazaki, I., Asanuma, M., Murakami, S., Takeshima, M., Torigoe, N., Kitamura, Y., & Miyoshi, K. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.003 · Cited by 78 · cited 1×
“Primary cultured mesencephalic neurons and astrocytes were prepared from the mesencephalon of SD rat embryos at 15 days of gestation [28].”
MethodSelf-citationGastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence
Pellegrini, C., Antonioli, L., Colucci, R., Ballabeni, V., Barocelli, E., Bernardini, N., Blandizzi, C., & Fornai, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.011 · Cited by 77
Fontanilla, C. V., Ma, Z., Wei, X., Klotsche, J., Zhao, L., Wisniowski, P., Dodel, R. C., Farlow, M. R., Oertel, W. H., & Du, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.009 · Cited by 67
Aschner, M. (1998) · PubMed · Cited by 58
Wu, Y., Chang, J., Lin, W., Li, C., Hsieh, M., Chen, H., Wang, T., Wu, W., Liu, C., & Liu, K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.011 · Cited by 53
Teraoka, M., Nakaso, K., Kusumoto, C., Katano, S., Tajima, N., Yamashita, A., Zushi, T., Ito, S., & Matsura, T. (2012) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.d-11-00030 · Cited by 52
Protective effects of metallothionein against dopamine quinone‐induced dopaminergic neurotoxicity
Miyazaki, I., Asanuma, M., Hozumi, H., Miyoshi, K., & Sogawa, N. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.046 · Cited by 48 · cited 1×
“In addition, MT directly scavenges free radicals [44,45].”
BackgroundSelf-citationMa, Z., Wei, X., Fontanilla, C. V., Noelker, C., Dodel, R. C., Hampel, H. J., & Du, Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.03.050 · Cited by 47 · cited 1×
“In those reports, CA and CGA showed antioxidative properties [23,24], anti-inflammatory activity [21,24–26], and inhibitory effects of mitochondrial damage [20].”
BackgroundMurakami, S., Miyazaki, I., Sogawa, N., Miyoshi, K., & Asanuma, M. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9480-1 · Cited by 40 · cited 1×
“In our previous studies, we reported that chronic injection with rotenone (50 mg/kg/day) induced neurodegeneration in the substantia nigra pars compacta (SNpc) and intestinal myenteric plexus in mice [27].”
BackgroundSelf-citationCaffeic Acid Inhibits Compound 48/80-Induced Allergic Symptoms in Mice
Hossen, M. A., Inoué, T., Shinmei, Y., Minami, K., Fujii, Y., & Kamei, C. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.64 · Cited by 35
Murakami, S., Miyazaki, I., Miyoshi, K., & Asanuma, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1577-2 · Cited by 31
Self-citation
Cited by
Nguyen, V., Taine, E. G., Meng, D., Cui, T., & Tan, W. (2024) · Nutrients · doi:10.3390/nu16070924 · Cited by 378
“CGA combined with ca ff eic acid prevents rotenone-caused Parkinsonian pathology in nigral dopaminergic and intestinal enteric neurons [224].”
BackgroundNeuroprotective Effects of Coffee Bioactive Compounds: A Review
Socała, K., Szopa, A., Serefko, A., Poleszak, E., & Wlaź, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010107 · Cited by 248
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Alam, M., Ahmed, S., Elasbali, A. M., Adnan, M., Alam, S., Hassan, M. I., & Pasupuleti, V. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860508 · Cited by 230
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186
Self-citationUsing Rotenone to Model Parkinson’s Disease in Mice: A Review of the Role of Pharmacokinetics
Innos, J., & Hickey, M. A. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00522 · Cited by 145
Metadata
- Authors
- Miyazaki, I., Isooka, N., Wada, K., Kikuoka, R., Kitamura, Y., & Asanuma, M.
- Affiliations
- Okayama University (JP)
- Corresponding author
- Miyazaki, Ikuko
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-03-07
- Volume
- 8
- Issue
- 3
- Pages
- 221
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6468520
- OpenAlex
- W2919600163
- Cited by
- 53
- References
- 50
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 10 · 2019: 1
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- All Japan Coffee Association (2016, 2018)
- Japan Society for the Promotion of Science (JP25461279, JP16K09673)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- caffeic acid, chlorogenic acid, rotenone, Parkinson's disease, neuroprotection, neurodegeneration, dopaminergic neurons, enteric neurons, myenteric plexus, metallothionein, astrocytes, oxidative stress, antioxidant activity, mitochondrial complex I inhibitors, glial cells
- MeSH terms
- Animals, Astrocytes, Caffeic Acids, Chlorogenic Acid, Coffee, Intestines, Male, Mesencephalon, Metallothionein, Mice, Inbred C57BL, Myenteric Plexus, Nerve Degeneration, Neuroglia, Rotenone, Down-Regulation, Up-Regulation, Neostriatum, Rats, Sprague-Dawley, Enteric Nervous System, Neuroprotective Agents, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.